NEK2 and breast carcinoma: Studies have shown that the high mRNA expression of NEK2 was related to the incidence, differentiation, metastasis and prognosis of multiple myeloma [7], pancreatic ductal adenocarcinoma [8], ovarian cancer [9], colorectal cancer [10] and breast cancer [11].